Hyperuricemia and Gout in Cyclosporin A-Treated Renal Transplant Recipients

Hsiao-Yi Lin(University of Michigan), Irving H. Fox(Takeda (United States)), Mark McQuillan(University of Michigan), Leslie L. Rocher, Thomas D. Palella(University of Michigan)
Advances in experimental medicine and biology
January 1, 1989
10.1007/978-1-4684-5673-8_48
Cited by 1

Related Papers

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
The safety of vedolizumab for ulcerative colitis and Crohn's disease
|Gut|2016|810
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
|Gastroenterology|2014|714
Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin
|New England Journal of Medicine|2005|694